Growth Company/VC News EMEA
 |
Search Highlights |
This quarter’s successful placements in EMEA include:
- Chief Medical Officer, vaccines developer, Austria
- CEO, immuno-oncology & cell-therapy, Netherlands
- Head M&A, outpatient services, Germany
- Senior Finance Manager, animal health, Spain
- Two Regional Heads of New Business, digital pathology software, DACH
- Commercial Director, diagnostics products, UK
- Non Executive Director, nanotechnology and drug particle engineering, Finland
- Venture Partner UK and Venture Partner US CNS-focused VC fund, UK/ US
- Principal, Life Science VC, Netherlands
- Managing Director, bioscience incubator, UK
Newly opened projects include:
|
|
 |
Themes |
Areas of focus this quarter include but are not limited to:
|
|
|
 |
Coulter News |
- Opening of new offices in Paris, Singapore and Sydney with 14 appointments worldwide
- Extremely successful year with group sales up by 31%, financial year 2018/19
- Promotion of Dr Kay Wardle to Managing Partner; over 20 years’ Life Science Search experience and extensive R&D expertise
 |
Coulter Partners |
- Global market leader and largest global executive search firm dedicated to the Life Sciences and committed to delivering outstanding leadership
- 85+ sector experts from a diversity of backgrounds working across 13 global offices.
- Unrivalled network with the Life Sciences community with c. 260+ assignments each year across all segments of the industry.
- Deep understanding of talent needs, business models, sector trends, scientific evolution, innovation and competitive positioning
- Large proportion of search work for VC, PE and angel-funded biotech, medtech, and digital health companies
- Working with 50+ VC and PE funds across US, UK and EMEA
- 400+ senior leadership assignments for investor portfolio companies
- Contact: s.kirby@coulterpartners.com